LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 13.16%959.76M | 25.58%432.73M | -15.88%101.71M | -16.02%69.87M | 18.71%355.47M | 55.44%848.12M | 58.56%344.58M | 52.51%120.91M | 29.11%83.19M | 62.20%299.44M |
Net income from continuing operations | -53.85%-1.29B | -91.70%-325.72M | -52.73%-327.9M | -39.79%-317.77M | -40.59%-317.82M | -5.07%-837.99M | 18.11%-169.91M | -6.58%-214.69M | -2.03%-227.32M | -36.35%-226.06M |
Operating gains losses | 167.12%31.42M | 90.39%-4.39M | ---- | ---- | 757.29%20.7M | -200.81%-46.81M | ---45.7M | ---- | ---- | --2.41M |
Depreciation and amortization | 52.21%182.51M | 43.29%50.13M | 44.89%47.05M | 54.05%45.11M | 73.64%40.22M | 88.72%119.9M | 77.36%34.99M | 83.49%32.47M | 81.08%29.28M | 133.00%23.16M |
Deferred tax | 71.34%-7.67M | 47.72%-7.14M | -172.77%-581K | 101.22%49K | --0 | -0.37%-26.76M | -884.50%-13.66M | -115.36%-213K | ---4.03M | 66.74%-8.87M |
Other non cash items | 14.50%163.25M | 35.01%46.48M | 19.72%41.7M | 15.60%37.92M | -8.30%37.16M | 35.39%142.57M | 16.61%34.43M | 36.60%34.83M | 29.99%32.8M | 61.73%40.52M |
Change In working capital | 13.53%443.59M | 20.63%254.82M | -39.15%-21.33M | -85.90%-45.17M | 16.51%255.27M | 34.95%390.72M | 57.95%211.24M | -176.50%-15.33M | -375.99%-24.3M | 43.65%219.1M |
-Change in receivables | 100.25%536K | 21.34%-328.17M | -56.14%-163.49M | -64.24%-87.13M | 59.64%579.32M | -27.02%-212.08M | -31.33%-417.22M | -17.85%-104.71M | -95.85%-53.05M | 36.09%362.89M |
-Change in prepaid assets | -50.08%29.85M | -253.34%-12.61M | 95.56%9.11M | -16.75%34.46M | -120.10%-1.11M | 2,159.06%59.8M | 151.15%8.22M | -88.73%4.66M | 40.98%41.39M | 109.61%5.53M |
-Change in payables and accrued expense | -5.54%179.73M | -63.48%38.31M | 11.16%45.36M | 130.40%129.51M | -187.44%-33.44M | 130.50%190.26M | 135.62%104.88M | 91.12%40.81M | 110.22%56.21M | -15.67%-11.64M |
-Change in other current liabilities | -17.81%-47.71M | -13.67%-13.37M | 28.79%-9.06M | -126.52%-11.92M | -24.26%-13.37M | 4.36%-40.5M | 10.69%-11.76M | -15.71%-12.72M | 46.38%-5.26M | -28.50%-10.76M |
-Change in other working capital | -28.50%281.19M | 8.26%570.66M | 70.84%96.74M | -73.14%-110.09M | -117.56%-276.12M | -6.19%393.24M | 20.86%527.12M | 79.23%56.63M | -511.65%-63.59M | -232.61%-126.92M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 13.16%959.76M | 25.58%432.73M | -15.88%101.71M | -16.02%69.87M | 18.71%355.47M | 55.44%848.12M | 58.56%344.58M | 52.51%120.91M | 29.11%83.19M | 62.20%299.44M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -77.09%190.65M | -56.96%224.89M | -146.80%-267.14M | 280.12%384.08M | 58.26%-151.18M | 239.20%832.26M | 906.63%522.57M | 488.71%570.86M | 151.43%101.04M | -90.85%-362.21M |
Capital expenditure reported | 13.77%-29.43M | 14.57%-6.01M | -1.45%-10.03M | 23.90%-5.99M | 20.74%-7.4M | -42.15%-34.13M | -5.02%-7.03M | ---9.89M | ---7.87M | ---9.34M |
Net PPE purchase and sale | -31.90%-46.28M | 13.73%-11.28M | -53.67%-13.44M | 19.93%-5.04M | -137.00%-16.52M | -39.63%-35.09M | -143.79%-13.07M | -2.83%-8.75M | -63.67%-6.3M | 5.98%-6.97M |
Net intangibles purchase and sale | --0 | --0 | --0 | ---- | ---- | -4,006.29%-28.74M | --0 | -110.95%-1.26M | ---- | ---- |
Net business purchase and sale | 89.01%-30.31M | -444.31%-13.18M | 45.07%-8.22M | 93.70%-8.91M | --0 | 23.97%-275.71M | 138.07%3.83M | 91.43%-14.96M | ---141.46M | 30.81%-123.11M |
Net investment purchase and sale | -75.34%297.41M | -52.61%255.35M | -138.99%-236.2M | 42.18%404.02M | 43.22%-126.51M | 750.32%1.21B | 1,362.66%538.84M | 1,340.41%605.72M | 253.46%284.15M | -63,754.29%-222.79M |
Net other investing changes | ---749K | ---- | ---- | --0 | ---749K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -77.09%190.65M | -56.96%224.89M | -146.80%-267.14M | 280.12%384.08M | 58.26%-151.18M | 239.20%832.26M | 906.63%522.57M | 488.71%570.86M | 151.43%101.04M | -90.85%-362.21M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 73.48%-226.52M | -35.53%-120.12M | 321.39%1.02B | -497.05%-490.55M | -183.24%-633.5M | -822.12%-854.1M | -121.11%-88.63M | -2,408.88%-459.65M | -267.24%-82.16M | -1,788.05%-223.66M |
Net issuance payments of debt | --2.3B | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net common stock issuance | -226.56%-1.93B | --0 | -153.98%-1.02B | ---400M | -169.35%-516.33M | ---591.73M | --0 | ---400.04M | --0 | ---191.69M |
Proceeds from stock option exercised by employees | 2.96%121.94M | -47.25%9.67M | 32.89%41.87M | -19.64%12.98M | 9.51%57.42M | 46.53%118.43M | 108.46%18.34M | 42.32%31.5M | 89.54%16.15M | 26.75%52.44M |
Net other financing activities | -88.06%-716.13M | -21.33%-129.79M | -238.27%-308.22M | -5.30%-103.52M | -106.86%-174.59M | -119.55%-380.8M | -118.84%-106.97M | -125.22%-91.12M | -218.23%-98.31M | -58.60%-84.4M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 73.48%-226.52M | -35.53%-120.12M | 321.39%1.02B | -497.05%-490.55M | -183.24%-633.5M | -822.12%-854.1M | -121.11%-88.63M | -2,408.88%-459.65M | -267.24%-82.16M | -1,788.05%-223.66M |
Net cash flow | ||||||||||
Beginning cash position | 86.15%1.78B | 116.65%2.17B | 69.81%1.31B | 101.11%1.35B | 86.15%1.78B | -13.22%956.73M | 19.63%999.9M | -16.28%773.38M | -37.91%670.84M | -13.22%956.73M |
Current changes in cash | 11.81%923.89M | -30.96%537.5M | 267.15%852.2M | -135.86%-36.6M | -49.85%-429.21M | 670.36%826.28M | 592.34%778.52M | 370.20%232.12M | 166.11%102.07M | -1,582.39%-286.43M |
Effect of exchange rate changes | -204.58%-6.19M | -297.15%-5.06M | 113.89%778K | 54.04%724K | -592.15%-2.63M | -117.68%-2.03M | -69.68%2.56M | -179.72%-5.6M | 120.52%470K | 110.49%535K |
End cash Position | 51.53%2.7B | 51.53%2.7B | 116.65%2.17B | 69.81%1.31B | 101.11%1.35B | 86.15%1.78B | 86.15%1.78B | 19.63%999.9M | -16.28%773.38M | -37.91%670.84M |
Free cash flow | 17.85%884.05M | 28.03%415.44M | -22.55%78.23M | 41.63%58.83M | 17.10%331.55M | 51.30%750.16M | 58.08%324.48M | 55.41%101.01M | -21.84%41.54M | 64.23%283.13M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |